These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1453197)

  • 21. Prognostic value of quality of life scores in patients with oesophageal cancer.
    Blazeby JM; Brookes ST; Alderson D
    Br J Surg; 2000 Mar; 87(3):362-73. PubMed ID: 10718971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality of life measures for patients receiving adjuvant therapy for breast cancer: an international trial. The International Breast Cancer Study Group.
    Hürny C; Bernhard J; Gelber RD; Coates A; Castiglione M; Isley M; Dreher D; Peterson H; Goldhirsch A; Senn HJ
    Eur J Cancer; 1992; 28(1):118-24. PubMed ID: 1567662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin.
    Reck M; Thatcher N; Smit EF; Lorigan P; Szutowicz-Zielinska E; Liepa AM; Winfree KB; Peterson P; Guba SC; Socinski MA
    Lung Cancer; 2012 Dec; 78(3):276-81. PubMed ID: 23043970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies in the quality of life of head and neck cancer patients: results of a two-year longitudinal study and a comparative cross-sectional cross-cultural survey.
    Morton RP
    Laryngoscope; 2003 Jul; 113(7):1091-103. PubMed ID: 12838004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early change in patient-reported health during lung cancer chemotherapy predicts clinical outcomes beyond those predicted by baseline report: results from Eastern Cooperative Oncology Group Study 5592.
    Eton DT; Fairclough DL; Cella D; Yount SE; Bonomi P; Johnson DH;
    J Clin Oncol; 2003 Apr; 21(8):1536-43. PubMed ID: 12697878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites.
    Quinten C; Martinelli F; Coens C; Sprangers MA; Ringash J; Gotay C; Bjordal K; Greimel E; Reeve BB; Maringwa J; Ediebah DE; Zikos E; King MT; Osoba D; Taphoorn MJ; Flechtner H; Schmucker-Von Koch J; Weis J; Bottomley A;
    Cancer; 2014 Jan; 120(2):302-11. PubMed ID: 24127333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.
    Brady MJ; Cella DF; Mo F; Bonomi AE; Tulsky DS; Lloyd SR; Deasy S; Cobleigh M; Shiomoto G
    J Clin Oncol; 1997 Mar; 15(3):974-86. PubMed ID: 9060536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality of life in elderly patients with localized breast cancer treated with radiotherapy. A prospective study.
    Arraras JI; Manterola A; Asin G; Illarramendi JJ; Cruz Sde L; Ibañez B; Delfrade J; Salgado E; Zarandona U; Cambra K; Vera R; Dominguez MA
    Breast; 2016 Apr; 26():46-53. PubMed ID: 27017241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of life and survival in advanced cervical cancer: a Gynecologic Oncology Group study.
    Chase DM; Huang HQ; Wenzel L; Cella D; McQuellon R; Long HJ; Moore DH; Monk BJ
    Gynecol Oncol; 2012 May; 125(2):315-9. PubMed ID: 22307062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors affecting baseline quality of life in two international adjuvant breast cancer trials. International Breast Cancer Study Group (IBCSG).
    Bernhard J; Hürny C; Coates AS; Peterson HF; Castiglione-Gertsch M; Gelber RD; Galligioni E; Marini G; Thürlimann B; Forbes JF; Goldhirsch A; Senn HJ; Rudenstam CM
    Br J Cancer; 1998 Sep; 78(5):686-93. PubMed ID: 9744512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Autologous cytokine-induced killer cells therapy on the quality of life of patients with breast cancer after adjuvant chemotherapy: a prospective study].
    Liang XF; Ma DC; Ding ZY; Liu ZZ; Guo F; Liu L; Yu HY; Han YL; Xie XD
    Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):764-8. PubMed ID: 24378099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of performance status and quality-of-life scores during chemotherapy for advanced breast cancer. The Australian New Zealand Breast Cancer Trials Group.
    Coates A; Forbes J; Simes RJ
    J Clin Oncol; 1993 Oct; 11(10):2050. PubMed ID: 8410129
    [No Abstract]   [Full Text] [Related]  

  • 33. Quality of life studies of the Australian New Zealand Breast Cancer Trials Group: approaches to missing data.
    Coates A; Gebski V
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):533-40. PubMed ID: 9549802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in health-related quality of life may predict recurrent breast cancer.
    Kenne Sarenmalm E; Odén A; Ohlén J; Gaston-Johansson F; Holmberg SB
    Eur J Oncol Nurs; 2009 Dec; 13(5):323-9. PubMed ID: 19596212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of life analyses in a clinical trial of DPPE (tesmilifene) plus doxorubicin versus doxorubicin in patients with advanced or metastatic breast cancer: NCIC CTG Trial MA.19.
    Liu J; Tu D; Dancey J; Reyno L; Pritchard KI; Pater J; Seymour LK
    Breast Cancer Res Treat; 2006 Dec; 100(3):263-71. PubMed ID: 16823511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective assessment of quality of life of female cancer patients.
    Greimel E; Thiel I; Peintinger F; Cegnar I; Pongratz E
    Gynecol Oncol; 2002 Apr; 85(1):140-7. PubMed ID: 11925134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer. The Cancer and Leukemia Group B.
    Kornblith AB; Hollis DR; Zuckerman E; Lyss AP; Canellos GP; Cooper MR; Herndon JE; Phillips CA; Abrams J; Aisner J
    J Clin Oncol; 1993 Nov; 11(11):2081-9. PubMed ID: 8229122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality of life of breast cancer patients receiving high-dose-intensity chemotherapy: impact of length of cycles.
    Genre D; Protière C; Macquart-Moulin G; Gravis G; Camerlo J; Alzieu C; Maraninchi D; Moatti JP; Viens P
    Support Care Cancer; 2002 Apr; 10(3):222-30. PubMed ID: 11904787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A dilemma in analysis: issues in the serial measurement of quality of life in patients with advanced lung cancer.
    Hollen PJ; Gralla RJ; Cox C; Eberly SW; Kris MG
    Lung Cancer; 1997 Oct; 18(2):119-36. PubMed ID: 9316004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognostic role of quality of life assessment in breast cancer.
    Staren ED; Gupta D; Braun DP
    Breast J; 2011; 17(6):571-8. PubMed ID: 21895846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.